Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T16:28:23.759Z Has data issue: false hasContentIssue false

4 - Biobanks and feedback

Published online by Cambridge University Press:  05 September 2014

Kadri Simm
Affiliation:
University of Tartu
Mairi Levitt
Affiliation:
Lancaster University
Darren Shickle
Affiliation:
University of Leeds
Get access

Summary

‘Genes now tell doctors secrets they can’t utter’ was the dramatic title of the New York Times article from August 2012 that described the problem of incidental findings in genetic research. Indeed, the issue of whether or not to disclose significant genetic information to participants of research that generally do not expect it, is a much-discussed topic in medical ethics and genetic journals and has now spilled over into general media. The right to know or not to know discussion in relation to biobank research is now almost entirely dominated by the so-called ‘incidentalome’ debate. Incidental findings are a well-known phenomenon in clinical care where, for example, a radiologist might find something unexpected from an image in addition to the information she was looking for. Genetic research, which is often based on biobank collections, is now similarly faced with such findings when researchers stumble upon DNA information that, while not the aim of the research itself, might be potentially very relevant to the donors. But while it might have been relatively straightforward for the radiologist to contact the patient or patient’s physician regarding incidental finds, the matter is much more complicated for researchers far removed (both institutionally and geographically) from the biological owners of the mostly anonymized samples.

The possibility of disclosing unplanned, unexpected and yet important genetic information to biobank donors raises numerous scientific, ethical, legal and practical issues. Leaving aside the legal aspects, this chapter gives an overview of these challenges and situates the debate within a larger, long-anticipated phenomenon of personalized medicine. I will start by looking back at the debates we had ten to fifteen years ago in relation to biobanks and potential feedback and will then proceed to discuss the recent arguments regarding feedback in the context of population biobanks and other large-scale genomic research.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×